Loading...

Maria Dall'Era, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
Address533 Parnassus Avenue
San Francisco CA 94117
Phone415-476-0783
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoResidency School of Medicine
    University of California, San FranciscoM.D.1997School of Medicine

    Collapse Overview 
    Collapse Overview
    Maria Dall’Era, M.D. is professor of medicine in the Division of Rheumatology. Within rheumatology, her subspecialty is systemic lupus erythematosus (SLE) and lupus nephritis. Dr. Dall’Era is the director of the UCSF Lupus Clinic in which she cares for > 200 patients with SLE. She is also the director of the Rheumatology Clinical Research Center in which she oversees the conduct of various clinical trials and observational research studies. Her research program is focused on three major areas: (1) the design and conduct of clinical trials of novel biologic agents for SLE and lupus nephritis, (2) a population-based SLE longitudinal cohort funded by the Centers of Disease Control and (3) a project in conjunction with the Lupus Nephritis Trials Network to determine the most appropriate renal outcome measures that should be utilized in lupus nephritis clinical trials.
    She is the co-chair of the Steering Committee for the Lupus Clinical Investigators Network (LuCIN).

    Dr. Dall’Era plays a large role in the education of trainees, both in the outpatient clinical arena, inpatient setting, and in the medical school. With a grant from the American College of Rheumatology’s Lupus Initiative, she created two pilot, interactive, on-line, virtual simulation SLE cases in collaboration with Dr. Michelle Lin. She incorporated novel features into the cases including a “differential diagnosis slider” in which the learner is required to re-adjust their differential diagnosis after case content is revealed. With a clinician scholar award grant from the American College of Rheumatology, she developed an interactive mobile app called PIVOT to teach clinical reasoning in rheumatology.

    Dr. Dall’Era is also active in the education of practicing physicians and lectures frequently on the topic of lupus at national conferences and review courses.

    Collapse Research 
    Collapse Research Activities and Funding
    Racial/ethnic and socioeconomic disparities in biologic and clinical SLE outcomes
    CDC/NCCDPHP U01DP005120Sep 1, 2014 - Aug 31, 2019
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Current challenges in the development of new treatments for lupus. Ann Rheum Dis. 2019 06; 78(6):729-735. Dall'Era M, Bruce IN, Gordon C, Manzi S, McCaffrey J, Lipsky PE. PMID: 30636212.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    2. Mycophenolate mofetil in the treatment of systemic lupus erythematosus. Curr Opin Rheumatol. 2011 Sep; 23(5):454-8. Dall'Era M. PMID: 21720247.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    3. Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies. Curr Rheumatol Rep. 2011 Aug; 13(4):308-16. Dall'era M, Chakravarty EF. PMID: 21584692.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    4. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide. Arthritis Care Res (Hoboken). 2011 Mar; 63(3):351-7. Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D. PMID: 21080348.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    5. Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial. Arthritis Rheum. 2007 Dec; 56(12):4142-50. Dall'Era M, Chakravarty E, Wallace D, Genovese M, Weisman M, Kavanaugh A, Kalunian K, Dhar P, Vincent E, Pena-Rossi C, Wofsy D. PMID: 18050206.
      View in: PubMed   Mentions: 88     Fields:    Translation:HumansCellsCTClinical Trials
    Maria's Networks
    Concepts (52)
    Derived automatically from this person's publications.
    _
    Co-Authors (4)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _